Physician profile
Marc S Eiseman
NPI 1124091855
$8,429.34
in general payments reported to CMS, 2019-2025
11 companies · $240 in 2025
The $240 reported for 2025 was more than what 84% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,878 · 2020: $792 · 2021: $518 · 2022: $1,313 · 2023: $1,552 · 2024: $1,137 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,459 · Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,459.00 |
| Food and Beverage | $469.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $4,852.00 | 2020-2024 | |
| Abbott Laboratories | $2,520.65 | 2019-2020 | |
| Edwards Lifesciences Corporation | $282.88 | 2019 | |
| Octapharma USA, INC. | $125.00 | 2025 | Fibryga |
| Heron Therapeutics, INC. | $125.00 | 2023 | Aponvie |
| Medtronic Vascular, INC. | $116.08 | 2019 | |
| Fresenius Kabi USA, LLC | $114.70 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $108.60 | 2022 | |
| Csl Behring | $105.03 | 2023 | Kcentra |
| Medtronic, INC. | $52.90 | 2022 | |
| Masimo Corporation | $26.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Eiseman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.